Literature DB >> 437897

[In vitro testing of newer cephalosporins (author's transl)].

G Linzenmeier, E Rosenthal.   

Abstract

The spectrum of activity of the newer cephalosporins is considerably wider and includes a number of gram-negative bacteria. Test results using cephalothin as 'class disc' of a class of antibiotics is therefore no longer valid for the newer members. Like cefazoline, all of the above-mentioned antibiotics are more effective against Escherichia coli. Cefuroxin and cefoxitin also display increased effectiveness against Klebsiella, as do cefoxitin against Serratia and indolpositive Proteus species, and cefamandole and cefuroxime against Enterobacter. Cefotaxim is superior to all other agents, as was also demonstrated in our own inhibition zone tests; in addition cefotaxim is effective against Pseudomonas aeruginosa. Since the various pathogens do not exhibit a uniform pattern of resistance to these antibiotics, the four new agents should for the time being be tested independently of cephalothin and cefazoline.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 437897     DOI: 10.1007/bf01641128

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  13 in total

1.  Comparative in vitro Activity of Cefuroxime and its Interactions with Aminoglycoside Antibiotics.

Authors:  H Gaya; E M Brown; P Friedman; S E Cox
Journal:  Proc R Soc Med       Date:  1977

2.  Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors:  F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

3.  [Animal studies on antibacterial activity of 10 cephalosporins (author's transl)].

Authors:  R Marre; B Züllich; H Beck; K Sack
Journal:  Zentralbl Bakteriol Orig A       Date:  1978-06

4.  [Selection of chemotherapeutic agents for the resistance determination of fast growing bacteria (minimal requirements)].

Authors: 
Journal:  Dtsch Med Wochenschr       Date:  1972-02-25       Impact factor: 0.628

5.  Which cephalosporin?

Authors:  J D Williams
Journal:  J Antimicrob Chemother       Date:  1978-03       Impact factor: 5.790

6.  Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.

Authors:  A L Barry; C Thornsberry; R N Jones; P C Fuchs; T L Gavan; E H Gerlach
Journal:  Am J Clin Pathol       Date:  1978-12       Impact factor: 2.493

7.  Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.

Authors:  I I Washington JA
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

8.  Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins.

Authors:  J Dubois; J C Pechère
Journal:  Infection       Date:  1978       Impact factor: 3.553

9.  Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.

Authors:  L Verbist
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies.

Authors:  H Wallick; D Hendlin
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

View more
  3 in total

1.  [Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)].

Authors:  C D Schwigon
Journal:  Infection       Date:  1982       Impact factor: 3.553

2.  [Bacteriological investigations with a new Semisynthetic oxy-beta-lactam antibiotic LY 127935 (AUTHOR'S TRANSL)].

Authors:  R Malottke
Journal:  Infection       Date:  1980       Impact factor: 3.553

3.  [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].

Authors:  I Braveny; H Dickert; K Machka
Journal:  Infection       Date:  1979       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.